Selective antagonists of benzodiazepines - PubMed (original) (raw)
. 1981 Apr 9;290(5806):514-6.
doi: 10.1038/290514a0.
- PMID: 6261143
- DOI: 10.1038/290514a0
Selective antagonists of benzodiazepines
W Hunkeler et al. Nature. 1981.
Abstract
Benzodiazepines produce most, if not all, of their numerous effects on the central nervous system (CNS) primarily by increasing the function of those chemical synapses that use gamma-amino butyric acid (GABA) as transmitter. This specific enhancing effect on GABAergic synaptic inhibition is initiated by the interaction of benzodiazepines with membrane proteins of certain central neurones, to which drugs of this chemical class bind with high affinity and specificity. The molecular processes triggered by the interaction of these drugs with central benzodiazepine receptors, and which result in facilitation of GABAergic transmission, are still incompletely understood. Theoretically, benzodiazepines could mimic the effect of hypothetical endogenous ligands for the benzodiazepine receptors, although there is no convincing evidence for their existence; in vitro studies indicate that benzodiazepines might compete with a modulatory peptide which is present in the supramolecular assembly formed by GABA receptor, chloride ionophore and benzodiazepine receptor and which reduces the affinity of the GABA receptor for its physiological ligand. The mechanisms of action of benzodiazepines at the molecular level are likely to be better understood following our recent discovery of benzodiazepine derivatives, whose unique pharmacological activity is to prevent or abolish in a highly selective manner at the receptor level all the characteristic centrally mediated effects of active benzodiazepines. Here, we describe the main properties of a representative of this novel class of specific benzodiazepine antagonists.
Similar articles
- Unusual interactions of benzodiazepine receptor antagonists.
Nutt DJ, Cowen PJ, Little HJ. Nutt DJ, et al. Nature. 1982 Feb 4;295(5848):436-8. doi: 10.1038/295436a0. Nature. 1982. PMID: 6276771 No abstract available. - In vivo bidirectional modulatory effect of benzodiazepine receptor ligands on GABAergic transmission evaluated by positron emission tomography in non-human primates.
Brouillet E, Chavoix C, Bottlaender M, Khalili-Varasteh M, Hantraye P, Fournier D, Dodd RH, Mazière M. Brouillet E, et al. Brain Res. 1991 Aug 23;557(1-2):167-76. doi: 10.1016/0006-8993(91)90131-e. Brain Res. 1991. PMID: 1660750 - Reversal of the antiaversive and anticonvulsant actions of diazepam, but not of progabide, by a selective antagonist of benzodiazepine receptors.
Lloyd KG, Bovier P, Broekkamp CL, Worms P. Lloyd KG, et al. Eur J Pharmacol. 1981 Oct 15;75(1):77-8. doi: 10.1016/0014-2999(81)90350-2. Eur J Pharmacol. 1981. PMID: 6274659 No abstract available. - Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy?
Mullen KD, Martin JV, Mendelson WB, Bassett ML, Jones EA. Mullen KD, et al. Lancet. 1988 Feb 27;1(8583):457-9. doi: 10.1016/s0140-6736(88)91245-7. Lancet. 1988. PMID: 2893876 Review. - Molecular aspects of the action of benzodiazepine and non-benzodiazepine anxiolytics: a hypothetical allosteric model of the benzodiazepine receptor complex.
Williams M. Williams M. Prog Neuropsychopharmacol Biol Psychiatry. 1984;8(2):209-47. doi: 10.1016/0278-5846(84)90160-x. Prog Neuropsychopharmacol Biol Psychiatry. 1984. PMID: 6146163 Review.
Cited by
- Development of non-sedating benzodiazepines with in vivo antischistosomal activity.
Mian MY, Sharmin D, Mondal P, Belayet JB, Hossain MM, McCusker P, Ryan KT, Fedorov AY, Green HA, Ericksen SS, Zamanian M, Tiruveedhula VVNPB, Cook JM, Chan JD. Mian MY, et al. Antimicrob Agents Chemother. 2024 Sep 4;68(9):e0036924. doi: 10.1128/aac.00369-24. Epub 2024 Aug 13. Antimicrob Agents Chemother. 2024. PMID: 39136467 - Development of non-sedating antischistosomal benzodiazepines.
Mian MY, Sharmin D, Mondal P, Belayet JB, Hossain MM, McCusker P, Ryan KT, Fedorov AY, Green HA, Ericksen SS, Zamanian M, Tiruveedhula VVNPB, Cook JM, Chan JD. Mian MY, et al. bioRxiv [Preprint]. 2024 Jan 29:2024.01.26.577323. doi: 10.1101/2024.01.26.577323. bioRxiv. 2024. PMID: 38352313 Free PMC article. Preprint. - The molecular basis of drug selectivity for α5 subunit-containing GABAA receptors.
Kasaragod VB, Malinauskas T, Wahid AA, Lengyel J, Knoflach F, Hardwick SW, Jones CF, Chen WN, Lucas X, El Omari K, Chirgadze DY, Aricescu AR, Cecere G, Hernandez MC, Miller PS. Kasaragod VB, et al. Nat Struct Mol Biol. 2023 Dec;30(12):1936-1946. doi: 10.1038/s41594-023-01133-1. Epub 2023 Oct 30. Nat Struct Mol Biol. 2023. PMID: 37903907 Free PMC article. - Remimazolam: Non-Clinical and Clinical Profile of a New Sedative/Anesthetic Agent.
Kilpatrick GJ. Kilpatrick GJ. Front Pharmacol. 2021 Jul 20;12:690875. doi: 10.3389/fphar.2021.690875. eCollection 2021. Front Pharmacol. 2021. PMID: 34354587 Free PMC article. Review. - Non-sedating benzodiazepines cause paralysis and tissue damage in the parasitic blood fluke Schistosoma mansoni.
McCusker P, Mian MY, Li G, Olp MD, Tiruveedhula VVNPB, Rashid F, Golani LK, Verma RS, Smith BC, Cook JM, Chan JD. McCusker P, et al. PLoS Negl Trop Dis. 2019 Nov 15;13(11):e0007826. doi: 10.1371/journal.pntd.0007826. eCollection 2019 Nov. PLoS Negl Trop Dis. 2019. PMID: 31730614 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources